In Moderna Row, Fed. Circ. Mulls What's 'For The Government'

By Theresa Schliep · November 5, 2026, 8:46 PM EST

The Federal Circuit on Thursday took a critical look at a lower court's decision concluding that Moderna had to face Arbutus' infringement claims over its COVID-19 vaccines, with one judge repeatedly...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Arbutus Biopharma Corporation v. Moderna, Inc.

Case Number

26-1581

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

March 30, 2026